直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

3rd Pharmaceutical and Biotechnology Pioneer Forum 2010

September 16-17, 2010

Shanghai, China

GenView

Hosted by GenView, Finnegan is an exclusive law firm sponsor of the 3rd annual pharmaceutical and biotechnology conference.  Finnegan partner Ningling Wang will present, "Managing IP in External Innovation Partnerships and Licensing."  The event will take place in Shanghai, China. 

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Related Professionals

Ningling Wang
Partner
Shanghai
+86 21 6194 2005
Email

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Seminar

IAM and WTR Live: Australasia IP Forum 2026

August 11, 2026

Melbourne

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP